New Drug Application News and Research

RSS
SCYNEXIS announces positive results from first interim efficacy analysis of FURI study

SCYNEXIS announces positive results from first interim efficacy analysis of FURI study

UC San Diego to conduct first U.S. clinical trial of intravenously administered bacteriophage therapy

UC San Diego to conduct first U.S. clinical trial of intravenously administered bacteriophage therapy

FDA warns Genetech for marketing stem cell products without approval

FDA warns Genetech for marketing stem cell products without approval

RNAi therapy shown to alleviate preeclampsia in animal model

RNAi therapy shown to alleviate preeclampsia in animal model

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

IU Philanthropic Venture Fund commits to invest $500,000 to NERx Biosciences company

IU Philanthropic Venture Fund commits to invest $500,000 to NERx Biosciences company

The Lancet Infectious Diseases journal publishes clinical trial results for Shionogi’s cefiderocol

The Lancet Infectious Diseases journal publishes clinical trial results for Shionogi’s cefiderocol

Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma

Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma

Scientists receive $5.1 million grant to develop stem cell-based therapy for blinding retinal conditions

Scientists receive $5.1 million grant to develop stem cell-based therapy for blinding retinal conditions

FDA grants Rare Pediatric Disease Designation for Immusoft’s Iduronicrin genleukocel-T

FDA grants Rare Pediatric Disease Designation for Immusoft’s Iduronicrin genleukocel-T

FDA and EMA accept Novartis' regulatory application for siponimod to treat SPMS in adults

FDA and EMA accept Novartis' regulatory application for siponimod to treat SPMS in adults

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

Cidara initiates Phase 3 clinical trial to evaluate efficacy, safety of rezafungin to treat invasive candidiasis

Cidara initiates Phase 3 clinical trial to evaluate efficacy, safety of rezafungin to treat invasive candidiasis

Alnylam announces positive results from Phase 3 Study of givosiran for treating acute hepatic porphyria

Alnylam announces positive results from Phase 3 Study of givosiran for treating acute hepatic porphyria

FDA grants Orphan Drug Designation to Myelo001 for treatment of Acute Radiation Syndrome

FDA grants Orphan Drug Designation to Myelo001 for treatment of Acute Radiation Syndrome

FDA approves Cassipa sublingual film for maintenance treatment of opioid dependence

FDA approves Cassipa sublingual film for maintenance treatment of opioid dependence

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Sunovion receives Complete Response Letter from FDA for dasotraline NDA

Sunovion receives Complete Response Letter from FDA for dasotraline NDA

Researchers publish new paper on developing vaccine candidates for Helminthic parasites

Researchers publish new paper on developing vaccine candidates for Helminthic parasites